Patents by Inventor Myrtle Gordon

Myrtle Gordon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Culture method
    Patent number: 9163234
    Abstract: The invention provides methods of culturing cells, particularly maintaining the differentiation potential of a population of cells with differentiation potential. The methods involve contacting cells with an inhibitor of miRNA-181a* and/or incubation in a serum-free medium. A serum-free medium is also provided. Also provided are progeny stem cells, methods of obtaining them, and uses thereof.
    Type: Grant
    Filed: October 6, 2011
    Date of Patent: October 20, 2015
    Assignee: Omnicyte Limited
    Inventor: Myrtle Gordon
  • Medium derived from stem cells as a pharmaceutical composition
    Patent number: 8652846
    Abstract: The invention provides an apoptosis-modulating cell-free composition comprising conditioned extracellular medium of a stem cell and uses thereof, particularly therapeutic uses. Also provided is a method of obtaining such a composition and an in vitro method of modulating apoptosis.
    Type: Grant
    Filed: October 2, 2009
    Date of Patent: February 18, 2014
    Assignee: Omnicyte Limited
    Inventors: Nagy A. Habib, Myrtle Gordon
  • CULTURE METHOD
    Publication number: 20130217125
    Abstract: The invention provides methods of culturing cells, particularly maintaining the differentiation potential of a population of cells with differentiation potential. The methods involve contacting cells with an inhibitor of miRNA-181a* and/or incubation in a serum-free medium. A serum-free medium is also provided. Also provided are progeny stem cells, methods of obtaining them, and uses thereof.
    Type: Application
    Filed: October 6, 2011
    Publication date: August 22, 2013
    Applicant: Omnicye Limited
    Inventor: Myrtle Gordon
  • MEDIUM DERIVED FROM STEM CELLS AS A PHARMACEUTICAL COMPOSITION
    Publication number: 20110262392
    Abstract: The invention provides an apoptosis-modulating cell-free composition comprising conditioned extracellular medium of a stem cell and uses thereof, particularly therapeutic uses. Also provided is a method of obtaining such a composition and an in vitro method of modulating apoptosis.
    Type: Application
    Filed: October 2, 2009
    Publication date: October 27, 2011
    Applicant: OMNICYTE LIMITED
    Inventors: Nagy A. Habib, Myrtle Gordon
  • Method of Fetal Cell Enrichment
    Publication number: 20080254460
    Abstract: The present invention provides a method of enriching fetal cells in a maternal blood sample wherein cells which are CD34+ and capable of adhering to a solid support are selected, an analysable sample of fetal cells obtainable by the methods of the invention and a kit for use in the methods of the invention. There is also provided a method of fetal gender determination and a method of diagnosing a fetal genetic abnormality.
    Type: Application
    Filed: May 10, 2006
    Publication date: October 16, 2008
    Applicant: REVEALCYTE
    Inventors: Natasa Levicar, Myrtle Gordon
  • Stem Cells
    Publication number: 20070274970
    Abstract: The present invention relates to an isolated stem cell population wherein said stem cells are CD34+, capable of self regeneration, capable of differentiation into ectodermal, mesodermal and endodermal cells and capable of adhering to tissue-culture grade plastic as well as to methods of isolation of said cells, methods of culturing and differentiation thereof, the progeny of such methods of differentiation as well as uses, including therapeutic uses of the stem cells and their differentiated progeny.
    Type: Application
    Filed: December 20, 2004
    Publication date: November 29, 2007
    Inventors: Myrtle Gordon, Nagy Habib